COVID-19

Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.

Information for infection preventionists to manage ESBL-producers even while fighting against COVID-19.

Kevin Kavanagh, MD, explains his concern about immunodysfunction and the possibility of its effects on hospitals.

New study shows home infusion therapy staff may have significant barriers to infection-surveillance training, and this could be leading to higher infection rates.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 13, 2023.

How do infection preventionists navigate the many—and often contradictory—requirements that fighting the COVID-19 pandemic has brought upon them?

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the great news about Ebola in Uganda. She also covers COVID-19 news, and what it has to do with the Clash of the Titans.

Have the CDC and EPA given enough correct guidance on how to use cleaning products during the COVID-19 pandemic, or is it “fundamentally flawed”?

How should health care workers, especially infection preventionists, give constructive criticism in their positions?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 6, 2023.

The public expects infectious disease experts to know how to protect them—and themselves—from getting ill from infectious diseases, including COVID-19. So, what happens when the infectious disease specialist gets ill herself?

The CDC genomic surveillance found that the XBB.1.5 variant has increased from causing 1% to over 40% in only a month.

Even during the COVID-19 pandemic, infection preventionists, nurses, environmental services personnel, and other health care workers cannot forget about C auris.

A recent study attempted to estimate the transmission of SARS-CoV-2 from humans to their pets and identify the risk factors, including food and water bowls and human-animal contact.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses infectious diseases as the new year begins.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 30, 2022.

Here are the top 5 video interviews from Infection Control Today for 2022.

Here is the most popular ICT® article of 2022.

However, improved IPC measures were not sufficient to protect HCP from occupational exposures during periods of high community incidence.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 4th, 3rd, and 2nd most popular.

Kevin Kavanagh, MD, discusses the continued concerns about COVID-19 vaccine efficacy reduction and what he believes should be done to protect against the further spread.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 7th, 6th, and 5th.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 10th, 9th, and 8th.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 24, 2022.

FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19.

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 15, 2022.

Immunocompromised individuals are at higher risk of contracting COVID-19. But do the current treatments protect them? If not, then what needs to be done?

Association for Professionals in Infection Control and Epidemiology released a statement on how to protect against COVID-19, influenza, and RSV.

Saskia v. Popescu covers the news about COVID-19 cases, Ebola, and cholera in the week before Christmas, 2022.